Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Genzyme COO: David Meeker will fill the newly created role of chief operating officer, the diversified biotechnology firm said March 30. The new position integrates all aspects of Genzyme's commercial organization. With Genzyme since 1994, Meeker has headed the Genetic Diseases, Biosurgery and Transplant businesses, and in 2009 initiated the transformation of the company's global manufacturing and quality operations. He will now oversee the firm's business units, country management organization and global market access functions

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028706

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel